Conexeu Sciences Inc. (NASDAQ:CNXU) Short Interest Up 56.4% in August

Conexeu Sciences Inc. (NASDAQ:CNXU) was the recipient of a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 202,485 shares, an increase of 56.4% from the August 15th total of 129,461 shares. Approximately 0.8% of the company’s stock are sold short. Based on an average daily volume of 321,266 shares, the short-interest ratio is currently 0.6 days.

Conexeu Sciences Stock Performance

CNXU stock opened at $5.30 on Friday. Conexeu Sciences has a 1 year low of $4.19 and a 1 year high of $18.79. The firm has a fifty day simple moving average of $7.67. The firm has a market cap of $149.51 million and a price-to-earnings ratio of -48.18.

Conexeu Sciences (NASDAQ:CNXU) last posted its earnings results on Monday, September 14th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). Sell-side analysts anticipate that Conexeu Sciences will post -0.4 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CNXU has been the topic of several research reports. Zacks Research raised Conexeu Sciences to a “hold” rating in a research report on Monday, June 29th. Wall Street Zen upgraded Conexeu Sciences to a “hold” rating in a report on Saturday, May 30th. Weiss Ratings began coverage on Conexeu Sciences in a research note on Monday, August 17th. They issued a “sell (e-)” rating for the company. Finally, HC Wainwright started coverage on Conexeu Sciences in a report on Monday, June 22nd. They issued a “buy” rating and a $20.00 price objective on the stock. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Conexeu Sciences has an average rating of “Hold” and an average target price of $20.00.

About Conexeu Sciences

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. — Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property (“IP”) developed over more than a decade at the University of British Columbia (the “University”) and the BC Professional Firefighters Burn and Wound Healing Laboratory.